AI assistant
INTEGRATED RESEARCH LIMITED — Board/Management Information 2017
Feb 27, 2017
65142_rns_2017-02-27_3e175599-fb9e-4b48-a658-1f2daab472a4.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Integrated Research Ltd > ABN 76 003 588 449 Level 9, 100 Pacific Highway, North Sydney NSW 2060 Australia t: +61 (2) 9966 1066 f: +61 (2) 9966 1042 e: [email protected]
==> picture [96 x 60] intentionally omitted <==
28 February 2017 Integrated Research Limited (ASX:IRI)
ASX Limited Company Announcements Office Exchange Centre 20 Bridge Street Sydney NSW 2000
Integrated Research Limited – Agreement for Interim CEO
Please refer to the following page with information of the Agreement for the company’s Interim-CEO.
Contact
David Purdue Company Secretary Integrated Research Limited ABN: 76 003 588 449
- ends -
About Integrated Research (ASX:IRI) – Integrated Research Limited is the leading global provider of proactive performance management software for critical IT infrastructure, payments and communications ecosystems. More than 1000 organizations in over 60 countries—including some of the world’s largest banks, airlines and telecommunication companies rely on IR Prognosis to provide business critical insights and ensure continuity-critical systems deliver high availability and performance for millions of their customers across the globe. For further information on IR, visit www.ir.com.
TM
Providing Business Insight
Integrated Research Limited ABN: 76 003 588 449
Summary of Agreement for Interim CEO
As per the company’s disclosure to the ASX on 16[th] February 2017, Mr Andrew Dutton has been appointed as interim CEO of Integrated Research.
Mr. Dutton’s services are provided via a contractual arrangement between Integrated Research and Odgers Interim Pty Ltd.
Remuneration for the interim CEO services provided, is comprised of a fee only.
Base Fee Component
Odgers Interim Pty Ltd will be paid a fee at the rate of $66,000 per month (plus GST), plus expenses as approved by Integrated Research.
Incentive Component
There is no incentive component payable.
Equity Component
There is no equity component.
Additional Benefits
There are no additional benefits provided.
Termination of the Agreement
The contractual arrangement continues until 31[st] July 2017, unless terminated earlier by either party. An extension may be negotiated if required.